drugset / Trial / NCT01548092

Stromal Vascular Fraction (SVF) for Treatment of Recto-vaginal Fistula

NCT01548092 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine safety of Stromal Vascular Fraction (SVF) for the treatment of recto-vaginal fistula.

Timeline

Start
2011-12
Primary completion
2012-07
Completion
2013-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Adipose-derived stem cells without expanded Cell therapy — Other

Indications